Deng, Yiqiao
Chen, Qichen
Guo, Chengyao
Chen, Jinghua
Li, Xin
Li, Zhiyu
Zhang, Yefan
Zhao, Jianjun
Zhou, Jianguo
Cai, Jianqiang
Yan, Tao
Wang, Xiaobing
Bi, Xinyu
Huang, Zhen
Zhao, Hong
Funding for this research was provided by:
National Key Research and Development Program of China (2023YFC3403800, 2023YFC3403804)
National Natural Science Foundation of China (82141127)
CAMS Innovation Fund for Medical Sciences (2021-I2M-C&T-B-057)
Non-Profit Central Research Institution Fund of the Chinese Academy of Medical Sciences (2019PT310026)
Sanming Project of Medicine in Shenzhen (SZSM202011010)
Article History
Received: 10 September 2024
Accepted: 9 January 2025
First Online: 21 January 2025
Declarations
:
: The study was approved by the Institutional Review Board of the Cancer Hospital, Chinese Academy of Medical Sciences (ID: NCC2021C-515), and informed consent was obtained from all the patients. The patients/participants provided written informed consent to participate in this study. The authors are accountable for all aspects of the work and for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
: Not applicable.
: The authors declare no competing interests.